A Rapid and Specific Diagnostic for Immunoglobulin Response to Zika Virus Exposure Based on De novo Designed Low Cost Hyper-stable Mini-Protein Epitopes

基于从头设计的低成本超稳定微型蛋白表位,对寨卡病毒暴露后的免疫球蛋白反应进行快速、特异性诊断

基本信息

  • 批准号:
    9334100
  • 负责人:
  • 金额:
    $ 18.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-08-20 至 2019-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT ABSTRACT The Zika virus is a mosquito-borne pathogen that has been implicated in a number of grave complications to fetuses carried by infected women. More recently, Zika has been linked to a spike in the number of cases of Guillain-Barre syndrome and microcephaly, a condition in which babies have severely hindered brain development and are born with smaller heads. Given this possible link to these serious birth defects, there is a pressing need for a way to definitively diagnose whether a woman has been exposed to the virus. Current methods to test for the presence of Zika miss the narrow time window before the virus clears the body after infection and serological tests are often hindered by cross-reactivity to other flaviviruses endemic in the same regions as Zika. The studies described here propose the development of an immunoassay targeting only those antibodies in the host’s polyclonal response that bind to those epitopes in the Zika coat protein that are not shared by other Flaviviruses. Such an assay could lead to more clinically specific immunoassays for the viruses in question. First we will develop novel computationally designed hyperstable viral epitope mimetics (VEMs) of the Zika envelope protein with structures that can specifically bind human anti-Zika immunoglobulins. Second these VEMs will be implemented in a rapid, low-cost paper-based sandwich immunoassay capable of detecting anti-Zika antibodies in human plasma at clinically relevant concentrations.
项目摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID BAKER其他文献

DAVID BAKER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID BAKER', 18)}}的其他基金

De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
针对 COVID-19 和未来大流行病的 Minibinder 拮抗剂的从头设计
  • 批准号:
    10296596
  • 财政年份:
    2021
  • 资助金额:
    $ 18.87万
  • 项目类别:
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
针对 COVID-19 和未来大流行病的 Minibinder 拮抗剂的从头设计
  • 批准号:
    10460648
  • 财政年份:
    2021
  • 资助金额:
    $ 18.87万
  • 项目类别:
De Novo Design of Minibinder Antagonists for COVID-19 and Future Pandemics
针对 COVID-19 和未来大流行病的 Minibinder 拮抗剂的从头设计
  • 批准号:
    10672446
  • 财政年份:
    2021
  • 资助金额:
    $ 18.87万
  • 项目类别:
Project 4: Novel reagent development to enable molecular characterization
项目 4:开发新型试剂以实现分子表征
  • 批准号:
    10359195
  • 财政年份:
    2020
  • 资助金额:
    $ 18.87万
  • 项目类别:
Project 4: Novel reagent development to enable molecular characterization
项目 4:开发新型试剂以实现分子表征
  • 批准号:
    10573273
  • 财政年份:
    2020
  • 资助金额:
    $ 18.87万
  • 项目类别:
Designed Vehicles for Blood Brain Barrier Traversal
设计用于穿越血脑屏障的车辆
  • 批准号:
    10400878
  • 财政年份:
    2019
  • 资助金额:
    $ 18.87万
  • 项目类别:
Designed Vehicles for Blood Brain Barrier Traversal
设计用于穿越血脑屏障的车辆
  • 批准号:
    10200639
  • 财政年份:
    2019
  • 资助金额:
    $ 18.87万
  • 项目类别:
Design of de novo interleukin mimics for targeted immunotherapy
用于靶向免疫治疗的从头白细胞介素模拟物的设计
  • 批准号:
    9796930
  • 财政年份:
    2019
  • 资助金额:
    $ 18.87万
  • 项目类别:
Designed Vehicles for Blood Brain Barrier Traversal
设计用于穿越血脑屏障的车辆
  • 批准号:
    10614470
  • 财政年份:
    2019
  • 资助金额:
    $ 18.87万
  • 项目类别:
Design of de novo interleukin mimics for targeted immunotherapy
用于靶向免疫治疗的从头白细胞介素模拟物的设计
  • 批准号:
    10475003
  • 财政年份:
    2019
  • 资助金额:
    $ 18.87万
  • 项目类别:

相似海外基金

Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
  • 批准号:
    10454419
  • 财政年份:
    2021
  • 资助金额:
    $ 18.87万
  • 项目类别:
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
  • 批准号:
    10672258
  • 财政年份:
    2021
  • 资助金额:
    $ 18.87万
  • 项目类别:
Novel Carbohydrate-binding Antibodies to Human Glycans Using the Lamprey System
使用 Lamprey 系统开发针对人类聚糖的新型碳水化合物结合抗体
  • 批准号:
    10293635
  • 财政年份:
    2021
  • 资助金额:
    $ 18.87万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 18.87万
  • 项目类别:
    Studentship
Covalent binding Antibodies as a Chemical Tool to Probe Immune Molecular Recognition
共价结合抗体作为探测免疫分子识别的化学工具
  • 批准号:
    565778-2021
  • 财政年份:
    2021
  • 资助金额:
    $ 18.87万
  • 项目类别:
    Alexander Graham Bell Canada Graduate Scholarships - Master's
Establishment of a novel serum diagnosis method for flaviviruses based on binding profiles of anti-flavivirus antibodies
基于抗黄病毒抗体结合谱建立黄病毒新型血清诊断方法
  • 批准号:
    20J22269
  • 财政年份:
    2020
  • 资助金额:
    $ 18.87万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of Antigen Glycosylation in Mucin Binding by Monoclonal Antibodies
抗原糖基化在单克隆抗体粘蛋白结合中的作用
  • 批准号:
    10045898
  • 财政年份:
    2020
  • 资助金额:
    $ 18.87万
  • 项目类别:
Do anti-DNA antibodies play a role in the pathogenesis of systemic lupus erythematosus by binding/entering live cells?
抗 DNA 抗体是否通过结合/进入活细胞在系统性红斑狼疮的发病机制中发挥作用?
  • 批准号:
    16K08929
  • 财政年份:
    2016
  • 资助金额:
    $ 18.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
N-Terminally fluorescent-labeled antibodies that show fluorescence change upon antigen-binding
N 末端荧光标记抗体,在抗原结合时显示荧光变化
  • 批准号:
    15K13739
  • 财政年份:
    2015
  • 资助金额:
    $ 18.87万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
(i) Identification of single-molecule protein complexes involved in cellular transport of prosthetic groups (Moco and heme) (ii) Generation of monoclonal antibodies directed against protein motifs involved in binding prosthetic groups
(i) 鉴定参与假体基团(Moco 和血红素)细胞运输的单分子蛋白复合物 (ii) 生成针对参与结合假体基团的蛋白基序的单克隆抗体
  • 批准号:
    226653713
  • 财政年份:
    2012
  • 资助金额:
    $ 18.87万
  • 项目类别:
    Research Units
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了